Strategic Choices in the Age of AI: Shaping the Future of Life Sciences

2026

Open publication workspace · Sign in to read the full PDF.

AI-generated summary

1) This report outlines the critical strategic choices life sciences companies must make to navigate the transformative impact of AI and generative models on their industry.
2) * Explores how AI is fundamentally reshaping R&D, market access, and distribution in life sciences.
* Identifies three strategic approaches for R&D (science champion, asset integrator, development engine) and three for market access and distribution (provider preference optimizer, direct-to-patient platform, distribution challenger).
* Discusses the implications of these shifts for public-private collaboration and the need for adaptive regulatory and policy frameworks.
3) AI, Life Sciences, Strategy, Innovation, Healthcare

Check the original publication for accuracy and context.